CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ortho Clinical Diagnostics Holdings plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ortho Clinical Diagnostics Holdings plc
1001 Route 202
Phone: (908) 218-8000p:908 218-8000 RARITAN, NJ  08869  United States
This company was Merged or Acquired on 5/27/2022.
This company ceased filing statements with the SEC on 6/6/2022.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Ortho Clinical Diagnostics Holdings PLC is an in vitro diagnostics (IVD) diagnostic company. The Company provides laboratory testing and blood-typing solutions to the clinical laboratory and transfusion medicine communities. The Company provides customized solutions for clinical outcomes, lab performance and staffing challenges. The Company operates through two lines of business such as Clinical Laboratories and Transfusion Medicine. Its Clinical Laboratories business focuses on clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across therapeutic areas. The Transfusion Medicine business is focused on immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions. Its Donor Screening business is focused on instruments and tests used for blood and plasma screening for infectious diseases for customers, which include some of the donor testing institutions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
4/3/20221/2/2022YesYes---

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer ChrisSmith 9/1/2020 9/1/2019
Chief Financial Officer Joseph M.Busky 7/1/2020 7/1/2020
Chief Operating Officer ChadDale 1/1/2019 1/1/2018
8 additional Officers and Directors records available in full report.

Business Names
Business Name
Branch of Ortho-Clinical Diagnostics Netherlands B.V.
Crimson Germany GmbH
Crimson International Assets LLC
44 additional Business Names available in full report.

General Information
Number of Employees: 4,800 (As of 4/3/2022)
Outstanding Shares: 237,734,877 (As of 4/29/2022)
Shareholders: 34
Stock Exchange: NASD
Federal Tax Id: 981151819


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 2, 2024